Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
CC transcript
Appointed director
Acq. announced
OPTIMER PHARMACEUTICALS INC (OPTR) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/24/2013 8-K Quarterly results
10/23/2013 8-K Submission of Matters to a Vote of Security Holders
08/02/2013 8-K Quarterly results
Docs: "Optimer Reports Second Quarter 2013 Financial Results"
08/01/2013 8-K Acquisition/merger/asset purchase announced
Docs: "Agreement and Plan of Merger, by and among Optimer Pharmaceuticals, Inc., Cubist Pharmaceuticals, Inc. and PDRS Corporation",
"Form of Contingent Value Rights Agreement between Cubist Pharmaceuticals, Inc. and Trustee",
"Amendment 1 to Co-Promotion Agreement, between Optimer Pharmaceuticals, Inc. and Cubist Pharmaceuticals, Inc"
07/30/2013 8-K Other Events, Financial Statements and Exhibits
Docs: "Questions and Answers For U.S. Employees",
"Questions and Answers For Canada Employees",
"Letter from Michael Bonney To Optimer Employees"
07/30/2013 8-K Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits
Docs: "Cubist Pharmaceuticals to Acquire Optimer Pharmaceuticals Transaction Adds Complementary Antibacterial Drug DIFICID® for CDAD and Bolsters Cubist’s Leadership in Acute Care Hospital Market Transaction Expected to be Accretive in First Year Post Closing DIFICID Co-Promote Agreeement Extended Lexington, Mass., and Jersey City, NJ – July 30, 2013 –"
05/09/2013 8-K Quarterly results
Docs: "Optimer Reports First Quarter 2013 Financial Results"
05/08/2013 8-K Entry into a Material Definitive Agreement
02/28/2013 8-K Quarterly results
Docs: "Optimer Reports Fourth Quarter and Fiscal Year 2012 Financial Results",
"Q4 and Fiscal Year 2012 Optimer Pharmaceuticals Earnings Conference Call Script"
02/27/2013 8-K Entry into a Material Definitive Agreement, Results of Operations and Financial Condition, Material Modifications to Rights o...
Docs: "Stockholder Protection Rights Agreement, between Optimer Pharmaceuticals, Inc. and American Stock Transfer & Trust Company, LLC, as Rights Agent, including as Exhibit A the forms of Rights Certificate and of Election to Exercise and as Exhibit B the form of Certificate of Designation and Terms of the Participating Preferred Stock of the Company",
"Letter Agreement, by and between Pedro Lichtinger and Optimer Pharmaceuticals, Inc",
"Letter Agreement, by and between Kurt Hartman and Optimer Pharmaceuticals, Inc",
"OPTIMER PHARMACEUTICALS' BOARD OF DIRECTORS APPOINTS BOARD CHAIRMAN, DR. HENRY MCKINNELL, CHIEF EXECUTIVE OFFICER COMPANY TO EXPLORE STRATEGIC ALTERNATIVES"
01/25/2013 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
01/07/2013 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "Optimer Pharmaceuticals Reports Preliminary 2012 Gross Product Sales of $74.4 Million 4th Quarter 2012 Gross DIFICID® Sales of $21.3 Million, Up 74.7% Over 4th Quarter 2011 and 14.4% Above the 3rd Quarter of 2012 Optimer Launches DIFICID Co-Pay Assistance Program and Announces Price Increase"
12/11/2012 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
11/01/2012 8-K Quarterly results
Docs: "Optimer Pharmaceuticals Reports Third Quarter 2012 Financial Results Webcast and Conference Call Today at 5:00 p.m. Eastern Time"
10/09/2012 8-K Conference call transcript
Docs: "Optimer Pharmaceuticals to Sell Remaining Ownership in Optimer Biotechnology, Inc. for U.S. $60 Million",
"Transcript of Conference Call on October 8, 2012"
08/03/2012 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "CMS Grants New Technology Add-on Payment to DIFICID® for Treatment of Clostridium difficile-associated Diarrhea"
07/31/2012 8-K Quarterly results
Docs: "Optimer Pharmaceuticals Reports Second Quarter 2012 Financial Results Webcast and conference call today at 5:00 p.m. Eastern Time"
07/24/2012 8-K Form 8-K - Current report
06/05/2012 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Optimer Pharmaceuticals Appoints Stephen Webster as Chief Financial Officer",
"Offer Letter, by and between Mr. Stephen W. Webster and Optimer Pharmaceuticals, Inc"
05/10/2012 8-K Quarterly results
Docs: "Certificate of Amendment of the Amended and Restated Certificate of Incorporation of Optimer Pharmaceuticals, Inc., as filed with the Secretary of State of the State of Delaware on May 10, 2012",
"Optimer Pharmaceuticals Reports First Quarter 2012 Financial Results 31% Net Sales Increase Puts Optimer on Track to Achieve First Year Sales Target Under Cubist Co-Promote Agreement Webcast and conference call today at 5:00 p.m. EDT",
"Optimer Pharmaceuticals, Inc. 2012 Equity Incentive Plan"
04/23/2012 8-K Form 8-K - Current report
04/09/2012 8-K Results of Operations and Financial Condition, Departure of Directors or Certain Officers; Election of Directors; Appointment...
Docs: "Optimer Pharmaceuticals Announces Personnel Changes"
03/30/2012 8-K Entry into a Material Definitive Agreement
03/07/2012 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "Optimer Reports Fourth Quarter and Fiscal Year 2011 Financial Results"
03/06/2012 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
01/12/2012 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
01/09/2012 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "Optimer Pharmaceuticals Provides Update on DIFICID® tablets Launch DIFICID Treatments Shipped by Wholesalers Grew Almost 87% in Fourth Quarter of 2011"
12/19/2011 8-K Entry into a Material Definitive Agreement
11/03/2011 8-K Form 8-K - Current report
09/30/2011 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
08/04/2011 8-K Form 8-K - Current report
06/10/2011 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "2006 Equity Incentive Plan, as amended"
06/03/2011 8-K Form 8-K - Current report
05/31/2011 8-K Other Events, Financial Statements and Exhibits
Docs: "FDA Approves Optimer's DIFICID™ Tablets for the Treatment of Patients with Clostridium difficile-Associated Diarrhea"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy